Bromide

Bromide

SCHEMBL50240

CC[N+](CC)(CC)CCC[n+]1ccc(C)c2ccccc21.[Br-].[Br-]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.38
KDM4E B2RXH2 5/20 0.55
POLB P06746 1/20 0.55
RECQL P46063 1/20 0.47
HTT P42858 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 3/20 0.41
GAA P10253 3/20 0.41
RAB9A P51151 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GLA P06280 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL53770 0.99 KDM4E (0.52) KDM4EPOLBRECQLHTTSMN1; SMN2
Bromide SCHEMBL4619723 0.85 KDM4E (0.57) KDM4EPOLBRECQLHTTSMN1; SMN2
SCHEMBL16865134 0.84 KDM4E (0.55) KDM4EPOLBRECQLHTTSMN1; SMN2
SCHEMBL13645489 0.83 KDM4E (0.64) KDM4EPOLBRECQLHTTSMN1; SMN2
SCHEMBL12201138 0.82 KDM4E (0.59) KDM4EPOLBRECQLHTTSMN1; SMN2
SCHEMBL13686278 0.81 KDM4E (0.62) KDM4EPOLBRECQLBCHEACHE
SCHEMBL18799222 0.81 KDM4E (0.52) KDM4EPOLBRECQLHTTSMN1; SMN2
Bromide SCHEMBL10439579 0.81 KDM4E (0.61) KDM4EPOLBRECQLHTTSMN1; SMN2
SCHEMBL16450366 0.80 KDM4E (0.57) KDM4EPOLBRECQLHTTSMN1; SMN2
Bromide SCHEMBL5394060 0.79 KDM4E (0.64) KDM4EPOLBRECQLHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129532-B2 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use THE UNIVERSITY OF CONNECTICUT (US) 2012-03-06 US disclosed
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042227-A1 AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE NLN, NME4, OAT ACHE 2187/4885KDM4E 1117/4885POLB 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.